| Presented by: | The Annenberg Center |
| Lecturer | J. Francois Eid, MD, Jacob Rajfer, MD, Raymond C. Rosen, PhD and Robert S.Tan, MD |
| Approximate duration: | 2 hrs. |
| Summary points: | This monograph discusses the long-term safety and tolerability profiles of the three PDE5 inhibitors used for ED, comorbidities associated with ED, questionnaires and diagnostic tools available to assess ED severity and efficacy of treatment, the importance of patient and partner preference and satisfaction with therapy, as well as current and potential indications for PDE5 inhibitors beyond the treatment of ED.
Expiration date: November 15, 2009. |
| Accreditation: | The Annenberg Center is accredited by the Accreditation Council for ContinuingMedical Education (ACCME) to provide continuing medical education for physicians.
TheAnnenberg Center designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits. |
| Other: | Text-only CME. |
E-Mail this webcast/CME to a colleague
PDE5 Inhibitors: Revolutionary Research, Current Clinical Considerations, and Future Directions
Go to webcast/CME
E-Mail this webcast/CME to a colleague
Remind me of this
